Literature DB >> 9692819

Oncocytic tumours.

G Tallini1.   

Abstract

Oncocytic tumours represent a distinctive set of lesions with distinctive granular cytoplasmic eosinophilia of the neoplastic cells. These cells are called oncocytes because of the "swollen" appearance they have as the result of a striking accumulation of mitochondria. Although generally uncommon, oncocytic tumours are by no means rare and have been reported, with different frequencies, in virtually every organ. A variety of biochemical and molecular changes have been identified, and the aberrant biogenesis of mitochondria in oncocytic cells bears intriguing similarities to that of a group of degenerative disorders known as mitochondrial encephalomyopathies. Although the relationship between the accumulation of mitochondria and the occurrence of tumours is unknown, investigation into the cellular alterations of oncocytes may further our knowledge of a variety of important biological processes such as proliferation, energy production and ageing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692819     DOI: 10.1007/s004280050209

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  48 in total

1.  Oncocytome de la surrénale : Étude de cas.

Authors:  Chiraz Chaari; Abdelmajid Khabir; Hela Mnif; Mohamed Abid; Mohamed Nabil Mhiri; Tahia Sellami Boudawara
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

2.  High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.

Authors:  Ivana Kurelac; Dario de Biase; Claudia Calabrese; Claudio Ceccarelli; Charlotte Ky Ng; Raymond Lim; Alan MacKay; Britta Weigelt; Anna Maria Porcelli; Jorge S Reis-Filho; Giovanni Tallini; Giuseppe Gasparre
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

Review 3.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

4.  [Not Available].

Authors:  Hellara Wadia; Lefi Mouni; Touffahi Mounir; Njim Leila; Farhane Samira; Saidi Radhia; Saad Hamadi
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

5.  Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.

Authors:  Andrea Ambrosini-Spaltro; Fabrizio Salvi; Christine M Betts; Giovanni P Frezza; Antonio Piemontese; Pietro Del Prete; Cristina Baldoni; Maria P Foschini; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

Review 6.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

7.  High uptake in schneiderian papillomas of the maxillary sinus on positron-emission tomography using fluorodeoxyglucose.

Authors:  F Y Lin; E M Genden; W L Lawson; P Som; L Kostakoglu
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

8.  Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

Authors:  Laura Maria Pradella; Martin Lang; Ivana Kurelac; Elisa Mariani; Flora Guerra; Roberta Zuntini; Giovanni Tallini; Alan MacKay; Jorge S Reis-Filho; Marco Seri; Daniela Turchetti; Giuseppe Gasparre
Journal:  Eur J Hum Genet       Date:  2013-02-06       Impact factor: 4.246

9.  A novel role for mitochondria in regulating epigenetic modification in the nucleus.

Authors:  Dominic J Smiraglia; Mariola Kulawiec; Gaia L Bistulfi; Sampa Ghoshal Gupta; Keshav K Singh
Journal:  Cancer Biol Ther       Date:  2008-08-01       Impact factor: 4.742

10.  Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid.

Authors:  Marco Volante; Francesca Bozzalla-Cassione; Roberta DePompa; Enrico Saggiorato; Armando Bartolazzi; Fabio Orlandi; Mauro Papotti
Journal:  Virchows Arch       Date:  2004-07-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.